Opioid-Induced Constipation in Advanced Illness: Safety and Efficacy of Methylnaltrexone Bromide

Opioid-Induced Constipation in Advanced Illness: Safety and Efficacy of Methylnaltrexone Bromide

Constipation, one of the major side effects of opiates used in palliative care, can impair patients’ quality of life to a point where it prevents sufficient pain control. Methylnaltrexone is a novel μ-receptor antagonist, which does not pass the blood brain barrier. It is licensed to treat opiate in...

Full description

Bibliographic Details
Main Authors:	S. Bader, K. Jaroslawski, H.E. Blum, G. Becker
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-01-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	https://doi.org/10.4137/CMO.S4867

Similar Items

Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide
by: Katri Elina Clemens, et al.
Published: (2010-02-01)

Methylnaltrexone in the treatment of opioid-induced constipation
by: Beverley Greenwood-Van Meerveld, et al.
Published: (2008-12-01)

Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes
by: Siemens W, et al.
Published: (2016-03-01)

Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
by: Rauck RL, et al.
Published: (2018-12-01)

Methylnaltrexone bromide methanol monosolvate
by: Xinbo Zhou, et al.
Published: (2012-03-01)

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies
by: Chamberlain BH, et al.
Published: (2021-09-01)

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
by: Webster LR, et al.
Published: (2015-10-01)

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain
by: Webster LR, et al.
Published: (2018-08-01)

Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone
by: Webster LR, et al.
Published: (2018-10-01)

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain [Corrigendum]
by: Webster LR, et al.
Published: (2018-06-01)

Laxatives or methylnaltrexone for the management of constipation in palliative care patients
by: Bridget Candy, et al.

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020-03-01)

Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials [version 1; peer review: 2 approved]
by: Neel Mehta, et al.
Published: (2021-09-01)

THE ROLE OF ENTERIC GLIA IN OPIOID-INDUCED CONSTIPATION
by: Bhave, Sukhada
Published: (2016)

A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy
by: Webster LR, et al.
Published: (2020-03-01)

Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studies
by: Iwao Osaka, et al.
Published: (2019-07-01)

Clinical utility of naloxegol in the treatment of opioid-induced constipation
by: Bruner HC, et al.
Published: (2015-06-01)

Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management
by: Lalit Kumar, et al.
Published: (2014-01-01)

Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients
by: Regina Gironés Sarrió, et al.
Published: (2021-01-01)

Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities
by: Alfred D. Nelson, et al.
Published: (2015-07-01)

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
by: Webster LR, et al.
Published: (2016-06-01)

Common Clinical Practice for Opioid-Induced Constipation: A Physician Survey
by: Coluzzi F, et al.
Published: (2021-07-01)

Prevalence and Risk Factors for Opioid-Induced Constipation in an Older National Veteran Cohort
by: Fern FitzHenry, et al.
Published: (2020-01-01)

Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study
by: Michelle S. Keller, et al.
Published: (2019-11-01)

Optimal treatment of opioid induced constipation in daily clinical practice – an observational study
by: Elisabeth C. W. Neefjes, et al.
Published: (2019-03-01)

Aspects of functional constipation : a trial of an opioid antagonist as a treatment and an investigation of the colonic microbiota associated with the illness
by: Bignell, Mark
Published: (2014)

An update on the efficacy and safety of aclidinium bromide in patients with COPD
by: Khuder Alagha, et al.
Published: (2011-02-01)

New Treatment Options for Chronic Constipation: Mechanisms, Efficacy and Safety
by: Michael Camilleri
Published: (2011-01-01)

Efficacy and safety of daikenchuto (TJ-100) in pregnant women with constipation
by: Hiroyuki Tsuda, et al.
Published: (2016-02-01)

Efficacy and safety of inulin supplementation for functional constipation: a systematic review protocol
by: Qing Yang, et al.
Published: (2021-04-01)

Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: A systematic review
by: Teresa Ruston, et al.
Published: (2013-10-01)

Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions
by: Gudin J, et al.
Published: (2020-02-01)

Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem
by: Yoon SC, et al.
Published: (2017-07-01)

Efficacy and Safety of Daikenchuto for Constipation and Dose-Dependent Differences in Clinical Effects
by: Tatsuya Hirose, et al.
Published: (2018-01-01)

Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial
by: Fuyuki, A., et al.
Published: (2022)

Commentary on Transcutaneous Acupoint Interferential Current Stimulation for Cancer Pain Patients With Opioid-Induced Constipation
by: Ivan Herrera-Peco PhD, et al.
Published: (2019-04-01)

What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report
by: Domenico Alvaro, et al.
Published: (2020-09-01)

The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study
by: Dohi, O., et al.
Published: (2020)

Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
by: Michael DeMicco, et al.
Published: (2017-11-01)

Efficacy and safety of elobixibat in hemodialysis patients with chronic constipation: a retrospective study
by: Takefumi Shono, et al.
Published: (2020-04-01)